First Amphetamine Transdermal Patch Approved for ADHD
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The donepezil (4) transdermal patch, named Adlarity, was FDA-approved in 2022 for treating mild, moderate, and severe dementia of the Alzheimer type.404”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [404]
Citations
Cites
Still being checked.
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 72
Lee, D., Shen, A. M., Garbuzenko, O. B., & Minko, T. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00967-x · Cited by 40
O’Connor, L., Carbone, S., Gobbo, A., Gamble, H., & Faraone, S. V. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2249414 · Cited by 24
New frontiers in pharmacological treatment of attention-deficit hyperactivity disorder
Noah, A. A., & Sedky, H. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04328-z · Cited by 14
Metadata
- Authors
- Larkin, H. D.
- Corresponding author
- Larkin, Howard D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2022-05-03
- Volume
- 327
- Issue
- 17
- Pages
- 1642
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4225321071
- Cited by
- 8
- References
- 0
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 1
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- amphetamine, transdermal patch, attention deficit hyperactivity disorder, drug approval, transdermal drug delivery, stimulant medication
- MeSH terms
- Administration, Cutaneous, Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Humans, Transdermal Patch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First Amphetamine Transdermal Patch Approved for ADHD. https://app.cochat.ai/papers/10.1001/jama.2022.5727
- The paper
- Larkin, H. D. (2022). First Amphetamine Transdermal Patch Approved for ADHD. JAMA. https://doi.org/10.1001/jama.2022.5727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.